Dragonfly Therapeutics, co-founded by David Raulet from UC Berkeley, highlighted in Nature Biotechnology
Development of a new vaccine against Tuberculosis from Sarah Stanley’s lab in the School of Public Health at Berkeley in collaboration with Aduro Biotech